Tag: life sciences
-

Pharma, Synthetic Bio Companies to Find Antibody Therapies
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases.
-

Digital Biofeedback Device Shown to Reduce PTSD
Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder.
-

FDA Sends Warning on Covid-19 Food Therapy Trials
The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms.
-

Health Journals Call for Emergency Climate Action
An editorial published in more than 200 journals calls for governments worldwide to take immediate action to mitigate climate changes affecting public health.
-

Small Biz Grant Funds Superbug Therapy Technology
A company designing synthetic viruses that attack antibiotic-resistant bacteria is receiving National Science Foundation funds to advance its work.
-

Biotechs Partner on Agitation Detection Technology
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders.
-

Immunotherapy Biotech Gains $108M in New Funds
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round.
-

Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-

Trial Shows Wearable Device Monitors Heart Rhythm Indicators
Results from a clinical trial show a device worn on the wrist can measure two key indicators of heart health as accurately as an electrocardiogram.
-

Small Biz Grant to Advance Cancer Chemotherapy Patch
A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors.